Therefore, this study supports future clinical trials that use 68Ga-FAPI PET/CT imaging as a noninvasive method to stratify and monitor patients with CRC for combined TGF-β signal inhibition and ICB therapy. Here, TGFB1 is linked to colorectal carcinoma.